The FDA was supposed to send an official letter notifying idenix of the clinical hold and there hasn't been any word regarding one yet from idenix. Will the receipt of an official letter be material enough to inform the public given that idenix has already notified investors of the clinical hold?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.